Education
About Us
Working with TipRanks
Follow Us
Theratechnologies (THTX)
:THTX
THTX Stock Chart & Stats
$3.39
$0.00(0.00%)
―
--
Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Acquisition PremiumThe acquisition offer from Future Pak represents a 126% premium to the closing price before the announcement, indicating a significant value proposition for shareholders.
Long-term SecurityPatent protection for EGRIFTA WR extends into 2033, providing long-term security for the product.
Sales GrowthThe launch of EGRIFTA WR is expected to allow the company to increase sales growth and maintain positive momentum.
Bears Say
Acquisition UncertaintyThere is skepticism about the success of Future Pak's acquisition offer, and it is likely to fall through despite recognizing the value of the EGRIFTA franchise.
Financial Performance2Q25 fully adjusted EPS of ($0.09) missed consensus expectations of ($0.01), which may indicate financial challenges.
Revenue ImpactAn expected one-time reduction in revenue due to a supply disruption resulted in a $10M — $12M decrease for FY25.
Theratechnologies News
THTX FAQ
What was Theratechnologies’s price range in the past 12 months?
Currently, no data Available
What is Theratechnologies’s market cap?
Currently, no data Available
When is Theratechnologies’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Theratechnologies’s earnings last quarter?
Theratechnologies released its earnings results on Jul 09, 2025. The company reported -$0.091 earnings per share for the quarter, missing the consensus estimate of -$0.015 by -$0.076.
Is Theratechnologies overvalued?
According to Wall Street analysts Theratechnologies’s price is currently Undervalued.
Does Theratechnologies pay dividends?
Theratechnologies does not currently pay dividends.
What is Theratechnologies’s EPS estimate?
Theratechnologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Theratechnologies have?
Currently, no data Available
What happened to Theratechnologies’s price movement after its last earnings report?
Theratechnologies reported an EPS of -$0.091 in its last earnings report, missing expectations of -$0.015. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Theratechnologies?
Currently, no hedge funds are holding shares in THTX
Technical Analysis
Ownership Overview
―
Insiders
0.10% Mutual Funds
― Other Institutional Investors
99.90% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---